OXiGENE (OXGN) Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference
11/17/2009 11:20:40 AM
More...
|
Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute
11/10/2009 11:08:14 AM
More...
|
Thirteen Abstracts Featuring Exelixis, Inc. (EXEL) Compounds Accepted for Presentation at the 2009 American Association for Cancer Research-National Cancer Institute-EORTC International Conference
11/4/2009 9:33:55 AM
More...
|
Low Cholesterol May Help Prevent Cancer, National Cancer Institute Study
11/4/2009 7:51:02 AM
More...
|
Astex Technology Announces a CRADA with the National Cancer Institute for its HSP90 inhibitor AT13387
11/3/2009 11:39:20 AM
More...
|
Solos Endoscopy, Inc. (SLSE.PK) Receives Additional Purchase Orders from National Cancer Institute and National Institutes of Health (NIH) for its MammoView(TM) Product Line Company's Signature Product Line Receives Positive Reviews
10/23/2009 8:28:19 AM
More...
|
Allegro Diagnostics Receives $2.8 Million SBIR Grant from National Cancer Institute
10/22/2009 10:56:09 AM
More...
|
NanoString Technologies Inc. Announces National Cancer Institute Has Adopted Its Gene Expression Technology
10/22/2009 9:33:44 AM
More...
|
PharmaGap Inc. (GAP) Advises That National Cancer Institute Test Results Are Completed and Expected To Be Provided To The Company Shortly
10/20/2009 2:18:14 PM
More...
|
TRACON Pharmaceuticals, Inc. Announces CRADA With National Cancer Institute to Study TRC105 in Prostate Cancer
10/19/2009 8:33:18 AM
More...
|
|